California Pauses Use of Johnson & Johnson COVID-19 Vaccine
By edhat staff
Santa Barbara County Public Health is following the CDC, FDA, and state recommendations to pause administration of the Johnson & Johnson COVID-19 vaccine.
Federal officials are reviewing cases where six women between the ages of 18 and 48 developed unusual types of blood clots 6 to 13 days after receiving the vaccine. This pause will last until the Federal Drug Administration (FDA) and Centers for Disease Control (CDC) complete their review, which is expected to take several days.
Nearly 7,000,000 people have received the Johnson & Johnson vaccine in the United States to date. People who received the vaccine in the last 3 weeks should look for any symptoms of these unusual clots, including severe headaches, abdominal or leg pain, and shortness of breath, and contact their medical provider if symptoms develop. People who don't have a medical provider can either go to an Emergency Room or an Urgent Care or call 2-1-1 to connect with a healthcare provider or call 9-1-1 if emergency response is needed.
While these adverse events appear to be extremely rare, the agencies are recommending a pause in the use of the vaccine out of an abundance of caution, and until a thorough review is completed. This pause will also ensure that health care providers are aware of the potential for these adverse events and understand the appropriate treatment for patients if a blood clot occurs.
The joint CDC and FDA Statement on Johnson & Johnson can be found at www.cdc.gov/media/releases/2021/s0413-JJ-vaccine.html.